Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Barbara Jonchere

3PUBLICATIONS

26CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Nov 01, 2022

Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo.

Barbara Jonchere, Justin Williams, Frederique Zindy

|Jun 16, 2022

Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma.

Allison Pribnow, Barbara Jonchere, Jingjing Liu

|Jul 12, 2020

Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer.

P Jake Slavish, Liying Chi, Mi-Kyung Yun

Pageof 1

Frequent Collaborators

2 joint publications

Martine F Roussel

2 joint publications

Anang A Shelat

2 joint publications

Jingjing Liu

2 joint publications

Jiyang Yu

2 joint publications

Sarah Robinson

1 joint publications

Zoran Rankovic

1 joint publications

Nancy E Martinez

1 joint publications

Sergio C Chai

1 joint publications

Kevin W Freeman

1 joint publications

Brandon M Young

Frequent Collaborators

2 joint publications

Martine F Roussel

2 joint publications

Anang A Shelat

2 joint publications

Jingjing Liu

2 joint publications

Jiyang Yu

Top Related Videos

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on : Mar 28, 2021

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos

Top Related Videos

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on : Mar 28, 2021

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos